PEN: Penumbra, Inc.
About
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.
Current Value
$235.291 Year Return
Current Value
$235.291 Year Return
Key Details
Market Cap
$9.10B
P/E Ratio
275.36
1Y Stock Return
2.99%
1Y Revenue Growth
16.96%
Dividend Yield
0.00%
Price to Book
8.2
Strategies that include PEN
Stock's related to PEN
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TFX | 44.59% | $8.97B | -10.85% | 0.71% |
| MDT | 40.04% | $109.01B | +8.12% | 3.27% |
| BIO | 36.99% | $8.98B | +4.73% | 0.00% |
| TXG | 36.61% | $1.64B | -68.30% | 0.00% |
| NVST | 36.02% | $3.49B | -15.41% | 0.00% |
| OPCH | 35.83% | $3.71B | -27.12% | 0.00% |
| MMSI | 35.59% | $6.10B | +45.96% | 0.00% |
| NMRK | 35.33% | $2.60B | +94.74% | 0.79% |
| ENOV | 35.20% | $2.53B | -10.59% | 0.00% |
| SNN | 34.67% | $11.12B | -0.04% | 2.98% |
| PD | 34.09% | $1.74B | -12.09% | 0.00% |
| CIGI | 33.60% | $7.24B | +35.37% | 0.21% |
| FMS | 33.53% | $12.97B | +12.47% | 2.97% |
| CNMD | 33.50% | $2.22B | -33.71% | 1.12% |
| PODD | 33.48% | $18.38B | +44.49% | 0.00% |
| NTRA | 33.43% | $21.40B | +200.46% | 0.00% |
| ATRC | 33.28% | $1.77B | -12.85% | 0.00% |
| DNB | 32.73% | $5.29B | +20.54% | 1.69% |
| OLO | 31.88% | $1.06B | +30.00% | 0.00% |
| NVRO | 31.82% | $158.88M | -73.60% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ORLY | -<0.01% | $69.31B | +22.06% | 0.00% |
| TEO | <0.01% | $1.69B | +87.97% | 0.00% |
| CXW | -0.02% | $2.43B | +62.08% | 0.00% |
| KGS | 0.04% | $3.37B | +110.22% | 4.11% |
| CL | -0.04% | $76.48B | +22.25% | 2.12% |
| WMB | 0.05% | $71.43B | +63.00% | 3.18% |
| MRCC | 0.05% | - | - | 11.82% |
| TW | 0.08% | $28.66B | +42.39% | 0.29% |
| GGAL | 0.10% | $6.81B | +291.69% | 0.50% |
| STVN | -0.10% | $4.95B | -32.48% | 0.32% |
| SXC | -0.12% | $1.05B | +39.93% | 3.52% |
| TXO | 0.14% | $737.26M | -1.80% | 13.22% |
| FWONK | -0.17% | $20.20B | +25.99% | 0.00% |
| LPTH | -0.17% | $62.27M | +33.05% | 0.00% |
| NEUE | -0.18% | $40.93M | -34.13% | 0.00% |
| FYBR | 0.18% | $8.65B | +66.27% | 0.00% |
| IMNN | -0.27% | $10.02M | -22.89% | 0.00% |
| GIS | 0.28% | $34.85B | -2.91% | 3.78% |
| CECO | -0.28% | $1.04B | +48.90% | 0.00% |
| AIXI | 0.28% | $43.94M | -72.60% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ACRS | -19.27% | $327.87M | +415.67% | 0.00% |
| NNE | -19.26% | $833.66M | +531.50% | 0.00% |
| TPST | -16.50% | $37.75M | -77.59% | 0.00% |
| MCK | -15.06% | $78.15B | +35.51% | 0.42% |
| GSL | -14.99% | $832.14M | +32.08% | 6.32% |
| HUSA | -14.92% | $16.69M | -11.56% | 0.00% |
| VIST | -14.55% | $4.75B | +67.10% | 0.00% |
| EDSA | -14.38% | $7.11M | -21.79% | 0.00% |
| MIST | -12.55% | $92.79M | -32.56% | 0.00% |
| CMBT | -11.60% | $2.46B | -29.63% | 13.05% |
| VRN | -11.35% | $3.23B | -25.43% | 6.21% |
| LFVN | -11.22% | $169.84M | +130.61% | 1.10% |
| TNK | -10.82% | $1.48B | -12.01% | 2.31% |
| RNR | -10.63% | $13.74B | +23.09% | 0.58% |
| LPG | -10.59% | $1.10B | -31.36% | 0.00% |
| NTZ | -10.52% | $47.64M | -30.94% | 0.00% |
| EG | -10.33% | $15.92B | -8.98% | 2.02% |
| HII | -10.23% | $7.50B | -19.92% | 2.70% |
| PGR | -10.15% | $149.10B | +57.29% | 0.45% |
| SU | -9.62% | $52.05B | +23.58% | 3.92% |
ETF's related to PEN
News
Finnhub
ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday,...
SeekingAlpha
For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary.
Yahoo
Morgan Stanley's latest report pegs the BCI market at $400 billion — signaling to investors that this revolutionary technology is the next big bet in medtech.
Yahoo
We came across a bullish thesis on Penumbra, Inc. (PEN) on Twitter by northeasternsvf. In this article, we will summarize the bulls’ thesis on PEN. Penumbra, Inc. (PEN)’s share was trading at $236.05 as of Nov 13th. PEN’s trailing and forward P/E were 271.32 and 64.10 respectively according to Yahoo Finance. Penumbra, headquartered in Alameda, California, is […]
Yahoo
Penumbra, Inc.'s ( NYSE:PEN ) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed...
Yahoo
Penumbra’s catheter was compared to other standard procedures in a 2,060 patient-strong analysis.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.